SCHEMBL2824844

SCHEMBL2824844

O=C(O)CCOc1ccc(-c2csc(N(CCCN3CCOCC3)C(=O)c3cccs3)n2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.59
MAPK1 P28482 3/20 0.59
LMNA P02545 3/20 0.59
TSHR P16473 7/20 0.55
KDM4E B2RXH2 6/20 0.55
SMN1; SMN2 Q16637 5/20 0.55
NPSR1 Q6W5P4 3/20 0.55
USP2 O75604 2/20 0.55
HSD17B10 Q99714 2/20 0.55
OPRM1 P35372 1/20 0.54
OPRD1 P41143 1/20 0.54
ALDH1A1 P00352 4/20 0.53
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
GSTO1 P78417 1/20 0.43
HPGD P15428 1/20 0.43
ROCK1 Q13464 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2830114 0.92 MAPT (0.60) MAPTMAPK1LMNATSHRKDM4E
SCHEMBL2826940 0.92 MAPT (0.51) MAPTMAPK1LMNATSHRKDM4E
SCHEMBL2826590 0.91 TSHR (0.62) MAPTMAPK1LMNATSHRKDM4E
SCHEMBL2827325 0.91 TSHR (0.65) MAPTMAPK1LMNATSHRKDM4E
SCHEMBL2830037 0.88 MAPT (0.74) MAPTMAPK1LMNATSHRKDM4E
SCHEMBL2829861 0.88 SMN1; SMN2 (0.65) MAPTMAPK1LMNATSHRKDM4E
SCHEMBL2826380 0.88 SMN1; SMN2 (0.67) MAPTMAPK1LMNATSHRKDM4E
SCHEMBL2826973 0.86 TSHR (0.60) MAPTMAPK1LMNATSHRKDM4E
SCHEMBL2829525 0.86 TSHR (0.61) MAPTMAPK1LMNATSHRKDM4E
SCHEMBL2826682 0.86 MAPT (0.60) MAPTMAPK1LMNATSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795290-B2 2-amido-thiazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof GENENTECH, INC. (US) 2010-09-14 US claimed
EP-2168578-A2 2-Amido-Thiazole-Based Compounds Exhibiting ATP-Utilizing Enzyme Inhibitory Activity, and Compositions, and Uses Thereof Genentech, Inc. (US) 2010-03-31 EP claimed
US-20090048313-A1 2-AMIDO-THIAZOLE-BASED COMPOUNDS EXHIBITING ATP-UTILIZING ENZYME INHIBITORY ACTIVITY, AND COMPOSITIONS, AND USES THEREOF GENENTECH, INC. (US) 2009-02-19 US claimed
US-7410988-B2 2-Amido-thiazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof GENENTECH, INC. (US) 2008-08-12 US claimed
EP-2620150-A2 2-Amido Thiazole Based Inhibitors of ATP-Utilizing Enyzmes Genentech, Inc. (US) 2013-07-31 EP disclosed
EP-2168578-A2 2-Amido-Thiazole-Based Compounds Exhibiting ATP-Utilizing Enzyme Inhibitory Activity, and Compositions, and Uses Thereof Genentech, Inc. (US) 2010-03-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048313-A1 2-AMIDO-THIAZOLE-BASED COMPOUNDS EXHIBITING ATP-UTILIZING ENZYME INHIBITORY ACTIVITY, AND COMPOSITIONS, AND USES THEREOF ATP5ME, ATP5MG, ATP5MK MAPT 3561/4885MAPK1 3940/4885LMNA 4104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.